AAAAAA

   
Results: 1-8 |
Results: 8
PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: MASUR H KAPLAN JE HOLMES KK BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Clinical infectious diseases, 25, 1997, pp. 299
1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: MASUR H KAPLAN JE HOLMES KK ARMSTRONG D BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 25, 1997, pp. 313-335
CIGARETTE-SMOKING, BACTERIAL PNEUMONIA, AND OTHER CLINICAL OUTCOMES IN HIV-1 INFECTION
Authors: BURNS DN HILLMAN D NEATON JD SHERER R MITCHELL T CAPPS L VALLIER WG THURNHERR MD GORDIN FM JOHNS S ELLISON J HICKSON MJ LEE J THOMPSON M CREAGH T MORRIS A ERNST J POLLARD C ANASTOS K BAR M DORAMAJIAN E BLATT D MOORE D RENZETTI R VERHEGGEN R LUSKINHAWK R TORRES RA TOWNLEY D CLANON K MORRIS B OWEN W BROSGART C CRANE LR EBRIGHT J SCHUMAN P VALLIER W FAIRCLOUGH C HOLLOWAY WJ WINSLOW D SZABO S BINCSIK A SWANSON K COHN DL REVES RR GRODESKY MJ MESARD CA GANS JE ELSADR W CAPPS L GUITY C HARDY M FUENTES L SARAVOLATZ L MARKOWITZ N KUMI J MASTROPOLAK D RYDER R VOGEL R HUTCHINSON J WALKER J PABLOVICH S SIMMONS P KIMMEL N KOCHER J WEISHOLTZ S SHERIDAN A TAYLOR VM BRAITHWAITE J SAMPSON JH GODBEY J LOVELESS M SALVESON C MARTINEZ N KERKERING TM WEBSTER C FISHER E LINK K GERNON L LABRIOLA A GIBERT C SCOTT J FINLEY E IRVIN K LOUIS TA BRELJE T DUCHENE A THOMPSON G WENTWORTH DN DEYTON LR SANVILLE J FOULKES M
Citation: Dn. Burns et al., CIGARETTE-SMOKING, BACTERIAL PNEUMONIA, AND OTHER CLINICAL OUTCOMES IN HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 13(4), 1996, pp. 374-383
PREDICTORS OF ORAL FUNGAL ISOLATION AMONG WOMEN WITH HIV
Authors: GREENBLATT R AGABIAN N WHITE T AMELI N CLANON K BROSGART C PALACIO H WOFSY C GREENSPAN J
Citation: R. Greenblatt et al., PREDICTORS OF ORAL FUNGAL ISOLATION AMONG WOMEN WITH HIV, Journal of dental research, 75, 1996, pp. 1771-1771
INSIGHTS FROM MONITORING THE CPCRA DIDANOSINE ZALCITABINE TRIAL
Authors: FLEMING TR NEATON JD GOLDMAN A DEMETS DL LAUNER C KORVICK J ABRAMS D BEERS D LOVELESS K MARTINEZ N MESARD CA REVES RR ROUFF JA KLEIN T MCDONALD R SLOTTEN R BROSGART C DREW L FESSEL J HUDSON R LOPEZ C THOMPSON S KUMI JO MASTROPOLAK D SARAVOLATZ LD KERKERING TM HIGGINSON RA GERNON L BAR M MENDEZ D ERNST J SCOTT J FINLEY B WARD D WISNIEWSKI T BRANDON W WALTER J CALHOUN C EBRIGHT JR SCHUMAN P BINCSIK A SWANSON K WINSLOW D SHERIDAN A TAYLOR V PEREZ G ELSADR W GUITY C JULEAU J SALVATI S DOWLING C SALVADOR GI BURNS AJ LAM SH CHILDRESS JF DEETS DL FLEMING TR MEYER KH POLLARD RB OFALLON JR RAHAL JJ WALTERS L WHITNEYWILLIAMS P WHITLEY RJ
Citation: Tr. Fleming et al., INSIGHTS FROM MONITORING THE CPCRA DIDANOSINE ZALCITABINE TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 9-18
MANAGING EARLY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: ELSADR W OLESKE JM AGINS BD BAUMAN K BROSGART C BROWN GM GEAGA JV GREENSPAN D HEIN K HOLZEMER WL JACKSON RE LINDSAY MK MAKADON HJ MOON MW RAPPOPORT CA SHERVINGTON WW SHULMAN LC WOFSY CB
Citation: W. Elsadr et al., MANAGING EARLY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, American journal of hospital pharmacy, 51(8), 1994, pp. 1003-1020
MANAGING EARLY HIV-INFECTION
Authors: ELSADR W OLESKE JM AGINS BD BAUMAN K BROSGART C BROWN GM GEAGA JV GREENSPAN D HEIN K HOLZEMER WL JACKSON RE LINDSAY MK MAKADON HJ MOON MW NEESE RF OWENS DK RAPPOPORT CA SCOTT G SHERVINGTON WW SHULMAN LC WOFSY CB
Citation: W. Elsadr et al., MANAGING EARLY HIV-INFECTION, American family physician, 49(4), 1994, pp. 801-814
RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF RIFAMPIN, ETHAMBUTOL, AND CIPROFLOXACIN FOR AIDS PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION
Authors: JACOBSON MA YAJKO D NORTHFELT D CHARLEBOIS E GARY D BROSGART C SANDERS CA HADLEY WK
Citation: Ma. Jacobson et al., RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF RIFAMPIN, ETHAMBUTOL, AND CIPROFLOXACIN FOR AIDS PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION, The Journal of infectious diseases, 168(1), 1993, pp. 112-119
Risultati: 1-8 |